AIFA meets
On 12 September, the 'AIFA Incontra' initiative was held at the agency's institutional headquarters in Via del Tritone, a new way of dialogue in transparency
13 September 2023
On 12 September, the 'AIFA Incontra' initiative was held at the agency's institutional headquarters in Via del Tritone, a new way of dialogue in transparency
Update 20 November 2023 The extraordinary State-Regions Conference held on 16 November 2023 sanctioned the long-awaited agreement on the Minister of Health's draft regulation,
This is our English version of the analysis 'Towards the reform of governance of the Italian Medicines Agency and the Single Committee' produced in collaboration
Nomos and Pharma Value have developed an in-depth document to analyse the AIFA reform defined in recent weeks in the Senate and understand its
In 2020, AIFA introduced the new simplified P&R negotiation procedures: simplified price and reimbursement procedure for drug negotiations
The Fund 5% for rare diseases, which allows access to medicines which do not have a MA in Italy, and which represent a hope of
The 5% Fund for rare diseases, which allows access to medicines that are not yet marketed in Italy and represent a hope of cure for
On 10 March 2022, the 'National Report on the Use of Antibiotics in Italy -2020' was presented on AIFA's YouTube channel.
On 7 January 2022, the Council of State (15 March 2021, No. 3095) issued its judgment on the appeal filed by Bayer against the
On 30 November 2021, AIFA defined the new access criteria for Law 326/2003. This law was supplemented by the Law of 10 November 2021
